MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-20-0122251
Vecta Biotech Private Limited
Vecta Biotech Private Limited - professional services in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.19 Cr
▲ 48% YoY
Net profit · FY 2025
₹17.43 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹39.5 Lakh
EBITDA margin 3%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹3 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Vecta Biotech Private Limited
Data last updated:
Vecta Biotech Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the advocacy segment of the professional services sector. It was incorporated on 03 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U74110MH2017PTC296833. Its GSTIN is 27AAGCG9032M1Z7 (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Vikram Subhash Chhabra and Karan Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R. N. Tagore Road Civil Lines, Nagpur, Maharashtra, India – 440001.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.19 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹17.43 Lakh (net margin 1.3%) and EBITDA of ₹39.5 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 252% over three years.
As per MCA filings, the company has open charges of ₹3 Cr on record.
Vecta Biotech Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-20-0122251). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74110MH2017PTC296833
Registration Number 296833
Incorporation Date 03 July 2017
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-20-0122251
CIN history
Vecta Biotech has one previous CIN (Corporate Identification Number): U74999MH2017PTC296833. The current CIN is U74110MH2017PTC296833, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110MH2017PTC296833 | Current |
| U74999MH2017PTC296833 | Previous |
Recognitions & Rankings of Vecta Biotech
Contact details
Vecta Biotech Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressR. N. Tagore Road Civil Lines, Nagpur, Maharashtra, India – 440001
- IndustryProfessional Services, Advocacy, Legal Services, Tax Consultant, Accounting
To see the full contact details of Vecta Biotech Private Limited, buy the company report.
Comprehensive company report
Vecta Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vecta Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vecta Biotech Private Limited, buy the company report.
Financials of Vecta Biotech Private Limited
FY 2025 filings availableVecta Biotech Private Limited reported revenue of ₹13.19 Cr (up 48% YoY) for FY 2025.
Revenue · FY 2025
₹13.19 Cr ▲ 48%
Net profit · FY 2025
₹17.43 Lakh margin 1.3%
EBITDA · FY 2025
₹39.5 Lakh margin 3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 48%
3 years · compounded
▲ 252%
EBITDA CAGR growth
1 year
▲ 223%
3 years · compounded
▲ 490%
5 years · compounded
▲ 297%
Revenue has grown at a compounded annual rate (CAGR) of 252% over three years, including 48% growth in the latest year. EBITDA rose 223% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.43 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vecta Biotech Private Limited, buy the company report.
Board of directors of Vecta Biotech Private Limited
Vecta Biotech has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikram Subhash Chhabra | Director | 01 Jul 2022 | 4 Years 3 Months | Current |
| Karan Arora Also directs: Simduiom Labs Private Limited, S H Arora and Associates LLP, Filament Lifesciences Private Limited and 2 more | Director | 03 Jul 2017 | 9 Years 3 Months | Current |
Peer comparison
Vecta Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Animal Pharma, Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neiss Labs Limited | ₹13.26 Cr (FY 2024) | 54.0% | Varanasi, Uttar Pradesh, India | |||
| Vecta Biotech Private Limitedthis company | ₹13.19 Cr (FY 2025) | ₹17.43 Lakh | 1.3% | 48.0% | Nagpur, Maharashtra, India | |
| Shankus Acme Pharma Private Limited | ₹13.15 Cr (FY 2025) | -3.0% | Mehsana, Gujarat, India | |||
| Kritika Remedies Private Limited | ₹13 Cr (FY 2025) | 68.0% | Haryana, India |
To see the full peer comparison of Vecta Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Dec 2024 | 101026110 | Others | ₹3 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Vecta Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vecta Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vecta Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCG9032M1Z7 | Maharashtra | Active | 04 Jul 2019 |
To see the full GST registrations and return filing status of Vecta Biotech Private Limited, buy the company report.
Recent activity
Vecta Biotech Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Nitin Ajabarao Wankhede ceased to be Director on 03 Dec 2023.
AGM
Vecta Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vecta Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Charges
A charge with Others amounted to Rs. 300.00 Lakh with Charge ID 101026110 was registered on 24 Dec 2024.
Ceased
Nitin Ajabarao Wankhede ceased to be Director.
Ceased
Vikram Subhash Chhabra ceased to be Additional Director.
Appointed
Vikram Subhash Chhabra was appointed as Director.
Ceased
Madhura Padmakar Bhide ceased to be Director.
Appointed
Karan Arora was appointed as Director.
Incorporation
03 Jul 2017
Vecta Biotech Private Limited was registered on 03 Jul 2017 with Roc Nagpur & aged 9 years 3 months as per MCA records.
Frequently asked questions
Vecta Biotech is an active private limited company based in Nagpur, Maharashtra, India. The company works in advocacy, within the professional services industry. It was incorporated on 03 July 2017 (9+ years old) and is registered under CIN U74110MH2017PTC296833.
Vecta Biotech has 2 current directors:
- Vikram Subhash Chhabra - Director
- Karan Arora - Director
The latest financial statements of Vecta Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Vecta Biotech is 27AAGCG9032M1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vecta Biotech is U74110MH2017PTC296833. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vecta Biotech was incorporated on 03 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Vecta Biotech by revenue are Neiss Labs Limited, Shankus Acme Pharma Private Limited, Kritika Remedies Private Limited, all in the Pharma industry (Animal Pharma, Formulations), with the same principal business activity (wholesale trading).
Nitin Ajabarao Wankhede ceased to be Director on 03 Dec 2023. Vikram Subhash Chhabra ceased to be Additional Director on 30 Sep 2022. Vikram Subhash Chhabra was appointed as Director on 01 Jul 2022. Vecta Biotech has 5 board changes on record in total.
Yes, Vecta Biotech is registered as an MSME under Udyam registration (number: UDYAM-MH-20-0122251).
The registered office of Vecta Biotech is at R. N. Tagore Road Civil Lines, Nagpur, Maharashtra, India – 440001.
Vecta Biotech operates in the professional services industry, in the advocacy segment.